DoubleRainbow Biosciences utilizes genomics, metabolomics, and synthetic biology to manufacture sustainable therapeutics and nutraceuticals derived from natural products. The company addresses the disruption in the supply of critical molecules essential for human health and well-being caused by global challenges such as climate change and geopolitical threats.
Funding
$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Global supply chain disruptions, climate change, and geopolitical instability threaten the consistent availability of critical natural molecules used in therapeutics and nutraceuticals. Traditional reliance on plant-derived sources is vulnerable to environmental factors and geopolitical risks, impacting the production of essential compounds for human health.
Solution
DoubleRainbow Biosciences leverages genomics, metabolomics, and synthetic biology to engineer microorganisms for the sustainable production of nature-inspired therapeutics and nutraceuticals. By recreating natural product biosynthesis pathways in engineered cells, the company offers a resilient and scalable alternative to traditional plant-based extraction. This approach ensures a stable supply of essential molecules, mitigating the impact of environmental and geopolitical disruptions while reducing reliance on resource-intensive agricultural practices. The company focuses on producing a diverse range of compounds, enhancing both human health and environmental sustainability.
Target Audience
The primary target audience includes pharmaceutical companies, nutraceutical manufacturers, and other businesses seeking a reliable and sustainable supply of natural compounds for use in their products.
Features
- Microbial engineering platform for heterologous production of complex natural products
- Genomics-guided identification and reconstruction of biosynthetic pathways
- Metabolomics-driven optimization of fermentation processes
- Sustainable biomanufacturing processes that reduce environmental impact
- Scalable production of therapeutics and nutraceuticals